Epstein JE, Tewari K, Lyke KE, Sim BK, Billingsley PF, Laurens MB, et al. Live attenuated malaria vaccine designed to protect through hepatic CD8 + T cell immunity. Science. 2011;334:475–80.
Article
CAS
PubMed
Google Scholar
Roestenberg M, Bijker EM, Sim BK, Billingsley PF, James ER, Bastiaens GJ, et al. Controlled human malaria infections by intradermal injection of cryopreserved Plasmodium falciparum sporozoites. Am J Trop Med Hyg. 2013;88:5–13.
Article
CAS
PubMed
PubMed Central
Google Scholar
Seder RA, Chang LJ, Enama ME, Zephir KL, Sarwar UN, Gordon IJ, et al. Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. Science. 2013;341:1359–65.
Article
CAS
PubMed
Google Scholar
Sheehy SH, Spencer AJ, Douglas AD, Sim BK, Longley RJ, Edwards NJ, et al. Optimising controlled human malaria infection studies using cryopreserved parasites administered by needle and syringe. PLoS ONE. 2013;8:e65960.
Article
CAS
PubMed
PubMed Central
Google Scholar
Shekalaghe S, Rutaihwa M, Billingsley PF, Chemba M, Daubenberger CA, James ER, et al. Controlled human malaria infection of tanzanians by intradermal injection of aseptic, purified, cryopreserved Plasmodium falciparum sporozoites. Am J Trop Med Hyg. 2014;91:471–80.
Article
PubMed
PubMed Central
Google Scholar
Hodgson SH, Juma EA, Salim A, Magiri C, Kimani D, Njenga D, et al. Evaluating controlled human malaria infection in kenyan adults with varying degrees of prior exposure to Plasmodium falciparum using sporozoites administered by intramuscular injection. Front Microbiol. 2014;5:686.
Article
PubMed
PubMed Central
Google Scholar
Bastiaens GJ, Van Meer MP, Scholzen A, Obiero JM, Vatanshenassan M, Van Grinsven T, et al. Safety, immunogenicity, and protective efficacy of intradermal immunization with aseptic, purified, cryopreserved Plasmodium falciparum sporozoites in volunteers under chloroquine prophylaxis: a randomized controlled trial. Am J Trop Med Hyg. 2015. https://doi.org/10.4269/ajtmh.15-0621.
Article
PubMed
Google Scholar
Gomez-Perez GP, Legarda A, Munoz J, Sim BK, Ballester MR, Dobano C, et al. Controlled human malaria infection by intramuscular and direct venous inoculation of cryopreserved plasmodium falciparum sporozoites in malaria-naive volunteers: effect of injection volume and dose on infectivity rates. Malar J. 2015;14:306.
Article
PubMed
PubMed Central
Google Scholar
Lyke KE, Laurens MB, Strauss K, Adams M, Billingsley PF, James E, et al. Optimizing intradermal administration of cryopreserved Plasmodium falciparum sporozoites in controlled human malaria infection. Am J Trop Med Hyg. 2015;93:1274–84.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mordmüller B, Supan C, Sim KL, Gómez-Pérez GP, Ospina Salazar CL, Held J, et al. Direct venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose-finding trial in two centres. Malar J. 2015;14:117.
Article
PubMed
PubMed Central
Google Scholar
Ishizuka AS, Lyke KE, Dezure A, Berry AA, Richie TL, Mendoza FH, et al. Protection against malaria at 1 year and immune correlates following PfSPZ vaccination. Nat Med. 2016;22:614–23.
Article
CAS
PubMed
Google Scholar
Epstein JE, Paolino KM, Richie TL, Sedegah M, Singer A, Ruben AJ, et al. Protection against Plasmodium falciparum malaria by PfSPZ vaccine. JCI Insight. 2017;2:e89154.
Article
PubMed
PubMed Central
Google Scholar
Mordmuller B, Surat G, Lagler H, Chakravarty S, Ishizuka AS, Lalremruata A, et al. Sterile protection against human malaria by chemoattenuated PfSPZ vaccine. Nature. 2017;542:445–9.
Article
PubMed
CAS
Google Scholar
Sissoko MS, Healy SA, Katile A, Omaswa F, Zaidi I, Gabriel EE, et al. Safety and efficacy of pfspz vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in mali: a randomised, double-blind phase 1 trial. Lancet Infect Dis. 2017;17:498–509.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lyke KE, Ishizuka AS, Berry AA, Chakravarty S, Dezure A, Enama ME, et al. Attenuated pfspz vaccine induces strain-transcending t cells and durable protection against heterologous controlled human malaria infection. Proc Natl Acad Sci U S A. 2017;114:2711–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Olotu A, Urbano V, Hamad A, Eka M, Chemba M, Nyakarungu E, et al. Advancing global health through development and clinical trials partnerships: a randomized, placebo-controlled, double-blind assessment of safety, tolerability, and immunogenicity of Plasmodium falciparum sporozoites vaccine for malaria in healthy Equatoguinean men. Am J Trop Med Hyg. 2018;98:308–18.
Article
PubMed
Google Scholar
Lell B, Mordmuller B, Dejon Agobe JC, Honkpehedji J, Zinsou J, Mengue JB, et al. Impact of sickle cell trait and naturally acquired immunity on uncomplicated malaria after controlled human malaria infection in adults in Gabon. Am J Trop Med Hyg. 2018;98:508–15.
Article
CAS
PubMed
Google Scholar
Jongo SA, Shekalage SA, Church LWP, Ruben AJ, Schindler T, Zenklusen I, et al. Safety, immunogenicity, and protective efficacy against controlled human malaria infection of Plasmodium falciparum sporozoite vaccine in Tanzanian adults. Am J Trop Med Hyg. 2018;99:338–49.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jongo SA, Church LWP, Mtoro AT, Chakravarty S, Ruben AJ, Swanson PA, et al. Safety and differential antibody and t-cell responses to the Plasmodium falciparum sporozoite malaria vaccine, PfSPZ vaccine, by age in Tanzanian adults, adolescents, children, and infants. Am J Trop Med Hyg. 2019;100:1433–44.
Article
CAS
PubMed
PubMed Central
Google Scholar
Schofield L, Villaquiran J, Ferreira A, Schellekens H, Nussenzweig RS, Nussenzweig V. Gamma-interferon, CD8 + T cells and antibodies required for immunity to malaria sporozoites. Nature. 1987;330:664–6.
Article
CAS
PubMed
Google Scholar
Weiss WR, Sedegah M, Beaudoin RL, Miller LH, Good MF. Cd8 + t cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. Proc Natl Acad Sci U S A. 1988;85:573–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Weiss WR, Mellouk S, Houghten RA, Sedegah M, Kumar S, Good MF, et al. Cytotoxic t cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes. J Exp Med. 1990;171:763–73.
Article
CAS
PubMed
Google Scholar
Doolan DL, Hoffman SL. The complexity of protective immunity against liver-stage malaria. J Immunol. 2000;165:1453–62.
Article
CAS
PubMed
Google Scholar
Rogers WO, Baird JK, Kumar A, Tine JA, Weiss W, Aguiar JC, et al. Multistage multiantigen heterologous prime boost vaccine for Plasmodium knowlesi malaria provides partial protection in Rhesus macaques. Infect Immun. 2001;69:5565–72.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rogers WO, Weiss WR, Kumar A, Aguiar JC, Tine JA, Gwadz R, et al. Protection of rhesus macaques against lethal Plasmodium knowlesi malaria by a heterologous DNA priming and poxvirus boosting immunization regimen. Infect Immun. 2002;70:4329–35.
Article
CAS
PubMed
PubMed Central
Google Scholar
Scally SW, Murugan R, Bosch A, Triller G, Costa G, Mordmuller B, et al. Rare pfcsp c-terminal antibodies induced by live sporozoite vaccination are ineffective against malaria infection. J Exp Med. 2018;215:63–75.
Article
CAS
PubMed
PubMed Central
Google Scholar
Vythilingam I, Chua TH, Liew JWK, Manin BO, Ferguson HM. The vectors of Plasmodium knowlesi and other simian malarias southeast asia: challenges in malaria elimination. Adv Parasitol. 2021;113:131–89.
Article
PubMed
Google Scholar
Cuenca PR, Key S, Jumail A, Surendra H, Ferguson HM, Drakeley CJ, et al. Epidemiology of the zoonotic malaria Plasmodium knowlesi in changing landscapes. Adv Parasitol. 2021;113:225–86.
Article
PubMed
Google Scholar
Jeyaprakasam NK, Liew JWK, Low VL, Wan-Sulaiman WY, Vythilingam I. Plasmodium knowlesi infecting humans in southeast asia: what’s next? PLoS Negl Trop Dis. 2020;14:e0008900.
Article
PubMed
PubMed Central
Google Scholar
Pichyangkul S, Spring MD, Yongvanitchit K, Kum-Arb U, Limsalakpetch A, Im-Erbsin R, et al. Chemoprophylaxis with sporozoite immunization in P. Knowlesi rhesus monkeys confers protection and elicits sporozoite-specific memory t cells in the liver. PLoS ONE. 2017;12:e0171826.
Article
PubMed
PubMed Central
CAS
Google Scholar
Weiss WR, Jiang CG. Protective CD8 + T lymphocytes in primates immunized with malaria sporozoites. PLoS ONE. 2012;7:e31247.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gwadz RW, Cochrane AH, Nussenzweig V, Nussenzweig RS. Preliminary studies on vaccination of rhesus monkeys with irradiated sporozoites of Plasmodium knowlesi and characterization of surface antigens of these parasites. Bull World Health Organ. 1979;57(Suppl 1):165–73.
PubMed
PubMed Central
Google Scholar
Hobbs CV, Neal J, Conteh S, Donnelly L, Chen J, Marsh K, et al. Hiv treatments reduce malaria liver stage burden in a non-human primate model of malaria infection at clinically relevant concentrations in vivo. PLoS ONE. 2014;9:e100138.
Article
PubMed
PubMed Central
CAS
Google Scholar
Hoffman SL, Billingsley P, James E, Richman A, Loyevsky M, Li T, et al. Development of a metabolically active,non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria. Hum Vaccines. 2010;6:97–106.
Article
CAS
Google Scholar
Murphy SC, Daza G, Chang M, Coombs R. Laser cutting eliminates nucleic acid cross-contamination in dried-blood-spot processing. J Clin Microbiol. 2012;50:4128–30.
Article
PubMed
PubMed Central
Google Scholar
Warhurst DC, Williams JE. Acp broadsheet no 148. July 1996. Laboratory diagnosis of malaria. J Clin Pathol. 1996;49:533–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cochrane AH, Santoro F, Nussenzweig V, Gwadz RW, Nussenzweig RS. Monoclonal antibodies identify the protective antigens of sporozoites of Plasmodium knowlesi. Proc Natl Acad Sci U S A. 1982;79:5651–5.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sullivan JS, Morris CL, Richardson BB, Galland GG, Sullivan JJ, Collins WE. Sporozoite transmission of three strains of Plasmodium knowlesi to aotus and Saimiri monkeys. J Parasitol. 1996;82:268–71.
Article
CAS
PubMed
Google Scholar
Collins WE, Sullivan JS, Nace D, Williams T, Williams A, Galland GG, et al. Additional observations on the sporozoite transmission of Plasmodium knowlesi to monkeys. J Parasitol. 2004;90:866–7.
Article
PubMed
Google Scholar
Collins WE, Contacos PG, Guinn EG. Studies on the transmission of simian malarias. Ii. Transmission of the h strain of Plasmodium knowlesi by Anopheles balabacensis balabacensis. J Parasitol. 1967;53:841–4.
Article
CAS
PubMed
Google Scholar
Dejon-Agobe JC, Ateba-Ngoa U, Lalremruata A, Homoet A, Engelhorn J, Paterne Nouatin O, et al. Controlled human malaria infection of healthy lifelong malaria-exposed adults to assess safety, immunogenicity and efficacy of the asexual blood stage malaria vaccine candidate GMZ2. Clin Infect Dis. 2019;69:1377–84.
Article
CAS
PubMed
Google Scholar
Laurens MB, Berry AA, Travassos MA, Strauss K, Adams M, Shrestha B, et al. Dose dependent infectivity of aseptic, purified, cryopreserved Plasmodium falciparum 7G8 sporozoites in malaria-naive adults. J Infect Dis. 2019;220:1962–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hodgson SH, Juma E, Salim A, Magiri C, Njenga D, Molyneux S, et al. Lessons learnt from the first controlled human malaria infection study conducted in nairobi, kenya. Malar J. 2015;14:182.
Article
PubMed
PubMed Central
Google Scholar
Richie TL, Billingsley PF, Sim BK, Epstein JE, Lyke KE, Mordmuller B, et al. Progress with plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines. Vaccine. 2015;33:7452–61.
Article
CAS
PubMed
PubMed Central
Google Scholar
Walsh DS, Pichyangkul S, Gettayacamin M, Tongtawe P, Siegrist CA, Hansukjariya P, et al. Safety and immunogenicity of RTS,S + Trap malaria vaccine, formulated in the AS02A adjuvant system, in infant rhesus monkeys. Am J Trop Med Hyg. 2004;70:499–509.
Article
CAS
PubMed
Google Scholar
Capone S, Reyes-Sandoval A, Naddeo M, Siani L, Ammendola V, Rollier CS, et al. Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector adch63 and mva prime-boost immunisation in non-human primates. Vaccine. 2010;29:256–65.
Article
CAS
PubMed
Google Scholar
Batten CJ, De Rose R, Wilson KM, Agy MB, Chea S, Stratov I, et al. Comparative evaluation of simian, simian-human, and human immunodeficiency virus infections in the pigtail macaque (Macaca nemestrina) model. AIDS Res Hum Retroviruses. 2006;22:580–8.
Article
CAS
PubMed
Google Scholar
Baroncelli S, Negri DR, Michelini Z, Cara A. Macaca mulatta, fascicularis and nemestrina in aids vaccine development. Expert Rev Vaccines. 2008;7:1419–34.
Article
CAS
PubMed
Google Scholar
Henning T, Fakile Y, Phillips C, Sweeney E, Mitchell J, Patton D, et al. Development of a pigtail macaque model of sexually transmitted infection/hiv coinfection using Chlamydia trachomatis, Trichomonas vaginalis, and shiv(sf162p3). J Med Primatol. 2011;40:214–23.
Article
PubMed
PubMed Central
Google Scholar
O’connor MA, Tisoncik-Go J, Lewis TB, Miller CJ, Bratt D, Moats CR, et al. Early cellular innate immune responses drive zika viral persistence and tissue tropism in pigtail macaques. Nat Commun. 2018;9:3371.
Article
PubMed
PubMed Central
CAS
Google Scholar
Cole AL, Cosgrove Sweeney Y, Lasseter AG, Gray JM, Beavis AC, Chong CF, et al. Evaluation of the pig-tailed macaque (Macaca nemestrina) as a model of human Staphylococcus aureus nasal carriage. Infect Immun. 2018;86:43.
Google Scholar
Parker DM. Humans, macaques, and malaria parasites in a shared and changing landscape. Lancet Planet Health. 2019;3:e157–8.
Article
Google Scholar